Meyka Pro banner
BGM Group Ltd.

BGM Group Ltd. (BGM) Stock Overview

Explore BGM Group Ltd.’s financial performance, market position, analyst ratings, and future outlook.

BGMNASDAQ
HealthcareDrug Manufacturers - Specialty & Generic
$0.30
$0.002(0.50%)
U.S. Market opens in 65h 15m

BGM Group Ltd. (BGM)

Meyka AI Score

Z

Key Financials

Market Cap110.8M
P/E Ratio-1.83
EPS (TTM)$-0.29
ROE-0.07%
Fundamental Analysis

AI Price Forecasts

1 Month$0.03
3 Months$0.00
1 Year Target$0.00

BGM Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of BGM Group Ltd. (NASDAQ: BGM) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, BGM Group Ltd.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of BGM on the NASDAQ shows an RSI of 49.12, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $0.00 for the NASDAQ listing.

Key metrics behind BGM Group Ltd.'s NASDAQ-traded stock include a P/E ratio of -1.83 and a market capitalization of 110.8M. Combined with our AI analysis, these give both institutional and retail investors a clear view of BGM on the NASDAQ.

Price Performance (NASDAQ: BGM)

1-Day Change
-2.45%
5-Day Change
-6.06%
1-Month Change
-6.73%
3-Month Change
-2.61%
6-Month Change
-73.53%
Year-to-Date (YTD) Change
-92.11%
1-Year Change
-96.15%
3-Year Change
-94.71%
5-Year Change
-94.71%
All-Time (Max) Change
-94.71%

Contact Information

86 28 6477 5180
No. 152 Hongliang East 1st Street, Chengdu, SIC, 610200

Company Facts

2,980 Employees
IPO DateJan 12, 2021
CountryCN
Actively Trading

Frequently Asked Questions